Search Press releases Keywords From To 27 Sep 2022 FINTEPLA[®▼] (fenfluramine) Approved in Japan for the Treatment of Seizures Associated with Dravet Syndrome Read More 23 Sep 2022 Disposal of own shares Read More 22 Sep 2022 UCB presents latest data from generalized myasthenia gravis portfolio at AANEM meeting Read More 20 Sep 2022 European Medicine Agency Accepts Marketing Authorization Applications for Bimekizumab in Psoriatic Arthritis and Axial Spondyloarthritis Read More 9 Sep 2022 Disposal of own shares Read More 9 Sep 2022 ASBMR 2022: 3D modelling of hip DXA scans in postmenopausal women with osteoporosis reveals superior improvements in bone density of romosozumab versus controls Read More Pagination First page Previous page Previous … Page 32 Page 33 Page 34 Page 35 Current page 36 Page 37 Page 38 Page 39 Page 40 … Page 36 of 60 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
